Dead space in over-the-counter syringes: The implications for HIV and HCV transmission.
University of North Carolina at Chapel Hill, UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, 2215 Kerr Hall CB #7573, Chapel Hill, NC 27599-7573, USA. Electronic address: oramsc@unc.edu.
Christine U
CU
Oramasionwu
University of North Carolina at Chapel Hill, UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, 2215 Kerr Hall CB #7573, Chapel Hill, NC 27599-7573, USA.
Stacy C
SC
Bailey
University of North Carolina at Chapel Hill, UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, 2215 Kerr Hall CB #7573, Chapel Hill, NC 27599-7573, USA.
Heather N
HN
Moore
Walgreens Pharmacy, Houston, TX, USA.
Christopher O
CO
Oramasionwu
Northwestern University, Division of General Internal Medicine, Chicago, IL, USA.
Allison L
AL
Russell
RTI International, Substance Abuse Treatment Evaluations and Interventions Program, Research Triangle Park, NC, USA.
William A
WA
Zule
D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission*; D006526:Hepatitis C / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D013594:Syringes